Zobrazeno 1 - 10 of 97 pro vyhledávání: '"H L, Elliott"'
1
Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the ‘ACTION’ database in patients with angina
Autor: H L Elliott, Peter A. Meredith
Publikováno v: Journal of Human Hypertension
A retrospective analysis of the database from A Coronary Disease Trial Investigating Outcome with Nifedipine (ACTION) evaluated the effectiveness of nifedipine gastrointestinal therapeutic system (GITS) (i) in combination with renin angiotensin syste
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464847b03e5466df3becf8c2cdee6d51
https://doi.org/10.1038/jhh.2010.19
Zobrazit plný text záznamu
2
Circulating Endothelial Cells in Renal Transplant Recipients
Autor: Patrick B. Mark, Alan G. Jardine, H L Elliott, A.S. Mohamed, Dianne Z. Hillyard, Jacqueline Thomson, Kenneth J. McDonald
Publikováno v: Transplantation Proceedings. 37:2387-2390
Circulating endothelial cells (CECs) are a marker of endothelial injury and endothelial dysfunction. We measured CECs in 95 patients with functioning renal transplants at risk of premature cardiovascular (CV) disease and in normal control subjects. W
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3efc90d1b9246de965ddf4739e39f507
https://doi.org/10.1016/j.transproceed.2005.03.126
Zobrazit plný text záznamu
4
ACE inhibition in Chronic Renal Failure and in the Treatment of Diabetic Nephropathy: Focus on Spirapril
Autor: H L Elliott, Alan G. Jardine
Publikováno v: Journal of Cardiovascular Pharmacology. 34:S31-S34
The management of hypertension and nephropathy, in both diabetes and other forms of renal disease, is usually based on blood pressure reduction through an angiotensin-converting enzyme (ACE) inhibitor-based treatment regimen. With particular respect
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8283e11100d884980d2aba8bb127ad2
https://doi.org/10.1097/00005344-199908001-00006
Zobrazit plný text záznamu
5
Renal effects of amlodipine in normotensive renal transplant recipients
Autor: J. Feehally, G. Venkat Raman, H. L. Elliott, R A Coates, R. Wilkinson, J. O. B. Olubodun, P J Griffin
Publikováno v: Nephrology Dialysis Transplantation. 14:384-388
Renal effects of amlodipine in normotensive renal transplant recipients. The use of cyclosporin A (CsA) has improved the success of renal transplantation, but is associated with hypertension and significant renal toxicity. Previous reports suggest th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::520dd7dd82df8bc5a5c31c9107b9becc
https://doi.org/10.1093/ndt/14.2.384
Zobrazit plný text záznamu
6
Population pharmacokinetics of gentamicin in patients with cancer
Autor: Maria Conceição do Rosário, C. A. Sharp, H. L. Elliott, Alison H. Thomson, Duncan I. Jodrell
Publikováno v: British Journal of Clinical Pharmacology. 46:229-236
Gentamicin is an aminoglycoside antibiotic that is active against gram-negative aerobic bacilli and is standard therapy in the prophylaxis and treatment of gram-negative infections [1]. Febrile neutropenic patients are at risk of developing overwhelm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::02e0b4aca34a99c5de1a02d90ed3a394
https://doi.org/10.1046/j.1365-2125.1998.00779.x
Zobrazit plný text záznamu
8
Clinical Studies with the Potassium Channel Activator Cromakalim in Normotensive and Hypertensive Subjects
Autor: Richard Donnelly, H. L. Elliott, Peter A. Meredith, John L. Reid
Publikováno v: Journal of Cardiovascular Pharmacology. 16:790-795
Summary: Eight normotensive subjects received single and multiple doses of cromakalim (1 mg) and placebo in a randomised double-blind cross-over study to examine general tolerance to cromakalim and its effects on blood pressure (BP), heart rate (HR),
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f752d42d74846e6adfc5395e3e175ed
https://doi.org/10.1097/00005344-199011000-00015
Zobrazit plný text záznamu
9
Vascular Pressor Responses in Treated and Untreated Essential Hypertension
Autor: Richard Donnelly, H. L. Elliott, John L. Reid, D. J. Sumner, Catherine A. Howie
Publikováno v: Journal of Cardiovascular Pharmacology. 16:191-196
Thirty-seven essential hypertensives received placebo for 3 weeks followed by nifedipine retard (n = 14) or enalapril (n = 13) or doxazosin (n = 10) as monotherapy for 6 weeks and attended study days to evaluate the effects of placebo, first dose, an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce632949a85d8a9e21396e444cea4f3f
https://doi.org/10.1097/00005344-199008000-00003
Zobrazit plný text záznamu
10
24-hour blood pressure control: its relevance to cardiovascular outcomes and the importance of long-acting antihypertensive drugs
Autor: H. L. Elliott
Publikováno v: Journal of human hypertension. 18(8)
This review article outlines the evidence that 24 h blood pressure (BP) measurements are particularly important predictors of adverse cardiovascular outcome. In turn, there is supportive evidence from a range of studies that 24 h BP control should be
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88cd87483e3f4e9e566bfaa64541eb93
https://pubmed.ncbi.nlm.nih.gov/15190262
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje